Editorials

Diabetes medications with cardiovascular protection after HARMONY Outcomes and DECLARE-TIMI 58: could metformin, pioglitazone, SGLT2 inhibitors and long-acting GLP-1 receptor agonists complement each other to save lives by different mechanisms?

Bob Ryder, Ralph DeFronzo … PDF HTML 1-5

Taking confidence from CREDENCE and navigating with SONAR: new evidence for reducing renal failure in diabetes

Peter H Winocour … PDF HTML 6-7

Original research

Prevalence of co-morbidities in a specialist weight management programme prior to bariatric surgery

Daniel Fountain, Mohammed Al Kharaiji, Sherif Awad, David Hughes, Iskandar Idris … PDF HTML 8-13

A comparison of follow-up rates of women with gestational diabetes before and after the updated National Institute for Health and Care Excellence guidance advocating routine follow-up, and the association with neighbourhood deprivation

Sebastian Walsh, Mahmoud Mahmoud, Htwe Htun, Sheena Hodgett, David Barton … PDF HTML 14-18

Does the use of a colour coded inpatient capillary blood glucose monitoring chart influence outcomes?

Dhiraj Sharma, Matthew Gerlach, Vivek Sharma, Ketan Dhatariya … PDF HTML 19-24

NICE targeted screening to identify gestational diabetes: who are we missing?

Canel Kucuk, Ali J Chakera, Elaine Macaninch … PDF HTML 25-28

A survey of the management of 16–18-year-olds presenting with diabetic ketoacidosis in the UK: a need for standardisation

Ketan Dhatariya, Peter Winocour, Andrew Raffles … PDF HTML 29-33

Current topics

Series: Cardiovascular outcome trials for diabetes drugs Saxagliptin and SAVOR-TIMI 53

Miles Fisher … PDF HTML 34-36

SGLT inhibitors and euglycaemic diabetic ketoacidosis: earlier observations rediscovered

Salem A Beshyah, Brian M Frier … PDF HTML 37-41

Learning from practice

A Health Equity Audit of the Diabetic Eye Screening Programmes in Cumbria and the North East

Balsam Ahmad, Fergus Neilson … PDF HTML 42-44

Low rates of hyponatraemia in patients with diabetes treated with variable rate intravenous insulin infusion (VRIII)

Zeenat Banu, Daniel Flanagan … PDF HTML 45-48

Changing inpatient diabetes care in a district general hospital

Marie Wallner, Basharat Andrabi, David Russell-Jones, Roselle Herring … PDF HTML 49-52

ENHIDE telehealth primary care support of adults with diabetes and chronic kidney disease: a pilot study – rationale and study design

Peter H Winocour, Karen Moore-Haines, Andrew Solomon, Anne Currie, Dawn Hardy … PDF HTML 53-62

Case reports

Recurrent spondylodiscitis secondary to hallux osteomyelitis

Aleksandra Staniszewska, Elizabeth Ballingall, Peter Schnatterbeck, Christopher R Lattimer, Amit Amin, William Lynn, Sanjeev Mehta … PDF HTML 63-65

Position statements

Association of British Clinical Diabetologists (ABCD) position statement on the use of sodium-glucose cotransporter-2 inhibitors in type 1 diabetes (updated 2019)

Umesh Dashora, Dipesh C Patel, Robert Gregory, Peter Winocour, Ketan Dhatariya, Dinesh Nagi … PDF HTML 66-72

Remission of type 2 diabetes: a position statement from the Association of British Clinical Diabetologists (ABCD) and the Primary Care Diabetes Society (PCDS)

Dinesh Nagi, Clare Hambling, Roy Taylor … PDF HTML 73-76

Meeting Reports

Joint ABCD-RA Meeting

Ana Pokrajac … PDF HTML 77

Abstracts

ABCD Renal Association Abstracts 2019

PDF HTML 78-79

ABCD Autumn Meeting Abstracts 2018

PDF HTML 79

ABCD News

ABCD and YDEF News

Dinesh Nagi, Umesh Dashora, Rebecca Reeve, Tim Robbins … PDF HTML 81-92